Cite
HARVARD Citation
Bruen, R. et al. (2018). Glucagon-like peptide 1 receptor agonist liraglutide impacts immune cell phenotypes in apolipoprotein e deficient mice during progression and regression of pre-established atherosclerosis. Atherosclerosis. pp. e1-. [Online].